News
November 17, 2018
QuaCell signed strategic cooperation agreement with Sartorius
On November 16, 2018, the 13th Zhongshan Forum for Health and Development, co-sponsored by the Government of Zhongshan City and twelve first-level academic societies, was officially opened at the Hilton Hotel Zhongshan.
Learn More
News
November 14, 2018
Finalist National-Quacell Biotechnology won the Second place in the Biomedical Industry Finals of the 7th China Innovation and Entrepreneurship Competition (Guangdong Division)
Yesterday, the 7th China Innovation and Entrepreneurship Competition (Guangdong Division) and the 6th“Pearl Angel Cup” Technology Innovation and Entrepreneurship Competition finals were held in Guangzhou, South China, New Materials Innovation Park.
Learn More
News
September 3, 2018
Awarded the Fifth Whampoa Cup "Creating Youth" Guangdong Innovation and Entrepreneurship Competition and the second prize of the first Guangdong-Hong Kong-Macao Greater Bay Area Youth Innovation and Entrepreneurship Group
QuaCell Biotechnology relies on "core materials for biological drug research and development and production --the CD medium industrialization project, the core material for biopharmaceutical R&D and production, advanced to the finals in the Fifth "Creating Youth" Guangdong Innovation and Entrepreneurship Competition in the Whampoa Cup 2018 and the first Guangdong-Hong Kong-Macao Greater Bay Area Youth Innovation and Entrepreneurship Competition. Second Prize in the Start-up Group".
Learn More
News
July 1, 2018
Obtained pre-A round of investment from 'National Venture Capital', 'Xiangshang Investment', 'Jiangmen Taikang' and other institutions
QuaCell Biotechnology completed the pre-A round of financing and obtained tens of millions of investment from Guangdong National Innovation Investment Management Co., Ltd. ("National Venture Capital"), Zhongshan Xiangshang Investment Management Co., Ltd. ("Xiangshang Investment")and Jiangmen Taikang Investment Partnership Co., Ltd. ("Jiangmen Taikang").
Learn More
News
May 1, 2018
CHO CD02, CHO CD04, and CHO Feed02 were launched
QuaCell Biotechnology’s three new products were officially launched, namely CHO CD02, CHO CD04, and CHO Feed02.
Learn More
News
April 13, 2018
QuaCell Biotechnology was registered and established
QuaCell Biotechnology Co., Ltd. (QuaCell Biotechnology) was registered and established, engaged in the field of biotechnology and biopharmaceutical product research and development production and sales.
Learn More
News
April 2, 2018
Completed a seed round of investment from Queshan Investment
Queshan Investment is a professional investment institution focusing on PE equity investment and management.
Learn More
News
January 5, 2018
Quacell Biotechnology and India Samas reached a CRO service cooperation
Two sides will conduct comprehensive cooperation on host cell lines, culture media, CRO services and other aspects in the six monoclonal antibody projects. Samarth Group, founded in 1963, is one of the top ten pharmaceutical groups in India.
Learn More